Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


LYNCH DANIEL Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2023 4 LYNCH DANIEL (Director) has filed a Form 4 on 2seventy bio, Inc.
Txns: Granted 8,400 shares @ $0
Granted 16,900 options to buy @ $11.81, valued at $199.6k
05/25/2023 4 LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,648 shares @ $0
Granted 13,774 options to buy @ $32.27, valued at $444.5k
06/09/2022 4 LYNCH DANIEL (Director) has filed a Form 4 on 2seventy bio, Inc.
Txns: Granted 7,200 shares @ $0
Granted 14,400 options to buy @ $13.51, valued at $194.5k
05/20/2022 4 LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 4,818 shares @ $0
Granted 15,318 options to buy @ $35.42, valued at $542.6k
11/17/2021 4 LYNCH DANIEL (Director) has filed a Form 4 on bluebird bio, Inc.
Txns: Disposed of 23,342 options to buy @ $0
Disposed of 10,500 options to buy @ $0
Disposed of 5,600 options to buy @ $0
Disposed of 4,200 options to buy @ $0
Disposed of 7,000 options to buy @ $0
11/16/2021 4 LYNCH DANIEL (Director) has filed a Form 4 on 2seventy bio, Inc.
Txns: Granted 2,803 shares @ $0
Granted 7,660 options to buy @ $8.55, valued at $65.5k
Granted 3,445 options to buy @ $39.07, valued at $134.6k
Granted 3,445 options to buy @ $287.25, valued at $989.6k
Granted 1,837 options to buy @ $74.34, valued at $136.6k
Granted 1,837 options to buy @ $172.37, valued at $316.6k
Granted 1,837 options to buy @ $284.33, valued at $522.3k
Granted 1,837 options to buy @ $189.47, valued at $348.1k
Granted 1,378 options to buy @ $99.53, valued at $137.2k
Granted 4,507 options to buy @ $50.98, valued at $229.8k
10/21/2021 3 LYNCH DANIEL (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc.
10/18/2021 3 LYNCH DANIEL (Director) has filed a Form 3 on 2seventy bio, Inc.
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 1,106 shares @ $0
Granted 6,998 options to buy @ $75.94, valued at $531.4k
01/06/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2020 4 LYNCH DANIEL (Director) has filed a Form 4 on Surface Oncology, Inc.
Txns: Granted 12,000 options to buy @ $4.35, valued at $52.2k
05/22/2020 4 LYNCH DANIEL (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 7,464 options to buy @ $38.03, valued at $283.9k
04/07/2020 4 LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Gifted 50,000 shares @ $0
09/16/2019 4 LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns: Granted 29,983 options to buy @ $18, valued at $539.7k
09/12/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
06/21/2019 4 LYNCH DANIEL (Director) has filed a Form 4 on Sesen Bio, Inc.
Txns: Granted 52,500 options @ $1.48, valued at $77.7k
06/20/2019 4 LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Granted 4,875 options to buy @ $96.77, valued at $471.8k
Granted 1,312 restricted stock units @ $0
06/19/2019 4 LYNCH DANIEL (Director) has filed a Form 4 on Translate Bio, Inc.
Txns: Granted 18,900 options to buy @ $10.2, valued at $192.8k
06/10/2019 4 LYNCH DANIEL (Director) has filed a Form 4 on bluebird bio, Inc.
Txns: Granted 1,400 shares @ $0
Granted 5,600 options to buy @ $122.01, valued at $683.3k
06/06/2019 4 LYNCH DANIEL (Director) has filed a Form 4 on Surface Oncology, Inc.
Txns: Granted 12,100 options to buy @ $3.69, valued at $44.6k
06/27/2018 3 LYNCH DANIEL (Director) has filed a Form 3 on Translate Bio, Inc.
06/25/2018 4 LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Granted 7,500 options to buy @ $69.79, valued at $523.4k
06/22/2018 4 LYNCH DANIEL (Director) has filed a Form 4 on bluebird bio, Inc.
Txns: Granted 1,400 shares @ $0
Granted 5,600 options to buy @ $183.1, valued at $1M
06/14/2018 4 LYNCH DANIEL (Director) has filed a Form 4 on Sesen Bio, Inc.
Txns: Granted 52,500 options @ $2.24, valued at $117.6k
04/18/2018 3 LYNCH DANIEL (Director) has filed a Form 3 on Surface Oncology, Inc.
02/16/2018 4 LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 12,500 shares @ $80.42, valued at $1M
02/14/2018 4 LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 1,530 shares @ $77.18, valued at $118.1k
Sold 2,590 shares @ $75.96, valued at $196.7k
Sold 5,636 shares @ $75.15, valued at $423.5k
Sold 3,748 shares @ $74.31, valued at $278.5k
Sold 3,996 shares @ $73.27, valued at $292.8k
11/17/2017 4 LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 1,600 shares @ $64.15, valued at $102.6k
Sold 2,200 shares @ $63.25, valued at $139.2k
Sold 1,200 shares @ $62.59, valued at $75.1k
09/20/2017 4 LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp
Txns: Sold 2,500 shares @ $60, valued at $150k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy